YPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Astellas Pharma Inc

Watchlist Manager

Watchlist

Price: 12.2 EUR Market Closed

Market Cap: €21.8B

	Astellas Pharma Inc F:YPHA	JP
	Tesoro Minerals Corp XTSX:TES	CA
	Gke Corporation Ltd SGX:595	SG
	East 33 Ltd ASX:E33	AU
	Petrotal Corp XTSX:TAL	US
C	CI Group PCL SET:CIG	TH
L	Longhorn Exploration Corp XTSX:LEX	CA
B	Bowler Metcalf Ltd JSE:BCF	ZA
U	Utility Business Alliance PCL SET:UBA	TH

Profitability Summary

Astellas Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

81%

Declining Gross Margin

82% > 81%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

13% > 21%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

7% > 16%

Exceptional Free Cash Flow Margin

20%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.